This company listing is no longer active
TCR2 Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
TCR2 Therapeutics has a total shareholder equity of $101.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $151.5M and $50.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$110.31m |
Equity | US$101.33m |
Total liabilities | US$50.18m |
Total assets | US$151.51m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2K7's short term assets ($140.5M) exceed its short term liabilities ($47.5M).
Long Term Liabilities: 2K7's short term assets ($140.5M) exceed its long term liabilities ($2.7M).
Debt to Equity History and Analysis
Debt Level: 2K7 is debt free.
Reducing Debt: 2K7 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2K7 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 2K7 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.4% each year